2024 Q3 Form 10-K Financial Statement

#000121390024077916 Filed on September 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q4 2023
Revenue $2.237M $2.313M $8.171M
YoY Change 7.05% 11.42% 21.15%
Cost Of Revenue $1.857M $2.410M $8.018M
YoY Change -7.08% 2.11% 9.66%
Gross Profit $379.4K -$97.35K $152.6K
YoY Change 319.19% -65.79% -126.87%
Gross Profit Margin 16.96% -4.21% 1.87%
Selling, General & Admin $1.367M $4.311M $6.853M
YoY Change 34.84% 176.05% -13.41%
% of Gross Profit 360.23% 4491.54%
Research & Development $29.90K $247.5K
YoY Change -65.11% -53.8%
% of Gross Profit 7.88% 162.23%
Depreciation & Amortization $11.81K $31.81K
YoY Change 21.75% -15.29%
% of Gross Profit 20.85%
Operating Expenses $1.367M $1.860M $6.853M
YoY Change -15.87% 18.4% -13.82%
Operating Profit -$987.4K -$1.958M -$6.700M
YoY Change -35.64% 5.49% -21.36%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $419.00 $0.00 $435.0K
YoY Change 1341.1%
Pretax Income -$987.0K -$1.958M -$6.265M
YoY Change -35.67% 5.78% -26.2%
Income Tax
% Of Pretax Income
Net Earnings -$987.0K -$1.958M -$6.265M
YoY Change -35.67% 5.78% -26.2%
Net Earnings / Revenue -44.12% -84.65% -76.68%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 1.344B shares 1.334B shares 1.313B shares
Diluted Shares Outstanding 1.349B shares 1.313B shares

Balance Sheet

Concept 2024 Q3 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $110.9K $110.9K
YoY Change 98.64% 98.64%
Cash & Equivalents $630.00 $110.9K
Short-Term Investments
Other Short-Term Assets $58.98K $58.98K
YoY Change -43.87% -43.87%
Inventory
Prepaid Expenses
Receivables $981.9K $517.3K $517.3K
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.085M $687.2K $687.2K
YoY Change -41.32% 168.23% 168.23%
LONG-TERM ASSETS
Property, Plant & Equipment $52.79K $72.95K $220.4K
YoY Change -32.76% -28.94% -20.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $8.940K $8.940K
YoY Change 0.0% 0.0%
Total Long-Term Assets $180.1K $249.6K $249.6K
YoY Change -31.48% -18.91% -18.91%
TOTAL ASSETS
Total Short-Term Assets $1.085M $687.2K $687.2K
Total Long-Term Assets $180.1K $249.6K $249.6K
Total Assets $1.265M $936.8K $936.8K
YoY Change -40.09% 66.1% 66.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.581M $1.568M $1.568M
YoY Change 13.52% -24.3% -24.7%
Accrued Expenses $230.0K $46.43K $80.00K
YoY Change 145.03% 18.34% 18.12%
Deferred Revenue $1.119M $533.4K
YoY Change -32.58%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.967M $2.181M $2.181M
YoY Change 50.77% -25.83% -25.83%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $113.9K $113.9K
YoY Change
Total Long-Term Liabilities $113.9K $113.9K
YoY Change -22.76% -22.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.967M $2.181M $2.181M
Total Long-Term Liabilities $113.9K $113.9K
Total Liabilities $3.053M $2.295M $2.295M
YoY Change 46.0% -25.69% -25.69%
SHAREHOLDERS EQUITY
Retained Earnings -$64.44M -$60.13M
YoY Change 10.78% 11.63%
Common Stock $1.344M $1.334M
YoY Change 0.74% 13.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.788M -$1.358M -$1.358M
YoY Change
Total Liabilities & Shareholders Equity $1.265M $936.8K $936.8K
YoY Change -40.09% 66.1% 66.1%

Cashflow Statement

Concept 2024 Q3 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$987.0K -$1.958M -$6.265M
YoY Change -35.67% 5.78% -26.2%
Depreciation, Depletion And Amortization $11.81K $31.81K
YoY Change 21.75% -15.29%
Cash From Operating Activities -$602.3K -$5.542M
YoY Change -89.19% 13.67%
INVESTING ACTIVITIES
Capital Expenditures $2.100K $2.102K
YoY Change -193.75% -89.98%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.100K -$2.102K
YoY Change -194.17% -149.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $599.4K
YoY Change -42.02%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -570.0 $5.599M
YoY Change -100.61% 441.59%
NET CHANGE
Cash From Operating Activities -602.3K -$5.542M
Cash From Investing Activities -2.100K -$2.102K
Cash From Financing Activities -570.0 $5.599M
Net Change In Cash -604.9K $55.07K
YoY Change -88.95% -101.44%
FREE CASH FLOW
Cash From Operating Activities -$602.3K -$5.542M
Capital Expenditures $2.100K $2.102K
Free Cash Flow -$604.4K -$5.544M
YoY Change -89.15% 13.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Entity File Number
EntityFileNumber
000-13215
CY2023 dei Entity Registrant Name
EntityRegistrantName
AIADVERTISING, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
30-0050402
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
1114 S. St. Mary’s Street, Suite 120
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
San Antonio
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78210
CY2023 dei City Area Code
CityAreaCode
(917)
CY2023 dei Local Phone Number
LocalPhoneNumber
273-8429
CY2023 dei Security12b Title
Security12bTitle
None
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
133441 usd
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1344231504 shares
CY2023 dei Auditor Firm
AuditorFirmId
2738
CY2023 dei Auditor Name
AuditorName
M&K CPAS, PLLC
CY2023 dei Auditor Location
AuditorLocation
The Woodlands, TX
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
110899 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55831 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
517344 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
95300 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
58982 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
105076 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
687225 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
256207 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
72948 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
102659 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
147480 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
175974 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8939 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8939 usd
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
20202 usd
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
20202 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
29141 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
29141 usd
CY2023Q4 us-gaap Assets
Assets
936794 usd
CY2022Q4 us-gaap Assets
Assets
563981 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1567751 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2071122 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
46430 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
39233 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
33572 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
28494 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
533386 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
791133 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2181139 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2940799 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
113907 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
147480 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2295046 usd
CY2022Q4 us-gaap Liabilities
Liabilities
3088279 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1334408773 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1334408773 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1175324203 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1175324203 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1334415 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1175330 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
56865961 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
49595914 usd
CY2023Q4 aiad Common Stock Payable Shares
CommonStockPayableShares
5000000 shares
CY2022Q4 aiad Common Stock Payable Shares
CommonStockPayableShares
5000000 shares
CY2023Q4 aiad Common Stock Payable Per Share
CommonStockPayablePerShare
0.1128
CY2022Q4 aiad Common Stock Payable Per Share
CommonStockPayablePerShare
0.1128
CY2023Q4 aiad Common Stock Payables
CommonStockPayables
564000 usd
CY2022Q4 aiad Common Stock Payables
CommonStockPayables
564000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-60125032 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53859673 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1358252 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2524298 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
936794 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
563981 usd
CY2023 us-gaap Revenues
Revenues
8170957 usd
CY2022 us-gaap Revenues
Revenues
6744297 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
8018382 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
7312215 usd
CY2023 us-gaap Gross Profit
GrossProfit
152575 usd
CY2022 us-gaap Gross Profit
GrossProfit
-567918 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6852960 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7952193 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
6852960 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
7952193 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-6700385 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-8520111 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
435026 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4990 usd
CY2022 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
25197 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
435026 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
30187 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6265359 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8489924 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-6265359 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-8489924 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6265359 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8489924 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1313030101 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1123312864 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1313030101 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1123312864 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2916997 usd
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1033884 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
123374 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1891371 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-8489924 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2524298 usd
CY2023 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
5000000 usd
CY2023 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
599428 usd
CY2023 aiad Stock Issued During Period Value Common Stock Payable
StockIssuedDuringPeriodValueCommonStockPayable
1831977 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-6265359 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1358252 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-6265359 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-8489924 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
272532 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1180 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
31813 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
37553 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
4990 usd
CY2022 us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
-25197 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
1831977 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1891371 usd
CY2022 us-gaap Other Noncash Expense
OtherNoncashExpense
123374 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
694576 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-403302 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-46094 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-77351 usd
CY2022 aiad Increase Decrease Costs In Excess Of Billings
IncreaseDecreaseCostsInExcessOfBillings
27779 usd
CY2022 aiad Increase Decrease In Customer Deposit
IncreaseDecreaseInCustomerDeposit
861 usd
CY2023 aiad Increase Decrease In Rightofuse Asset
IncreaseDecreaseInRightofuseAsset
28494 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-514188 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1279395 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
7197 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-32925 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-28495 usd
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-257747 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
299498 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5542258 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4413732 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2102 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20973 usd
CY2022 aiad Proceeds From The Sale Of Discontinued Operations
ProceedsFromTheSaleOfDiscontinuedOperations
25197 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2102 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4224 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
599428 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1033884 usd
CY2023 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
5000000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5599428 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1033884 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
55068 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3375624 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55831 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3431455 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110899 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55831 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
186706 usd
CY2022 aiad Change In Right Of Use Asset
ChangeInRightOfUseAsset
-70608 usd
CY2022 aiad Retired Stock Issuance
RetiredStockIssuance
2940 usd
CY2023 aiad Exercise Of Stock Options
ExerciseOfStockOptions
3931 usd
CY2022 aiad Exercise Of Stock Options
ExerciseOfStockOptions
3190 usd
CY2023 aiad Working Capital
WorkingCapital
1493914 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
191889 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5619 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The preparation of financial statements in conformity with GAAP requires the use of estimates and assumptions by management in determining the reported amounts of assets and liabilities, disclosures of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.  Estimates are primarily used in our revenue recognition, the allowance for doubtful account receivable, fair value assumptions in accounting, intangible assets and long-lived asset impairments and adjustments, the deferred tax valuation allowance, and the fair value of stock options and warrants. </p>
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
110899 usd
CY2023Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
0 usd
CY2023Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
533386 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
791133 usd
CY2023Q4 aiad Costs In Excess Of Billing
CostsInExcessOfBilling
0 usd
CY2022Q4 aiad Costs In Excess Of Billing
CostsInExcessOfBilling
0 usd
CY2023 aiad Third Parties Revenues
ThirdPartiesRevenues
8170957 usd
CY2023 us-gaap Revenues Net Of Interest Expense
RevenuesNetOfInterestExpense
8170957 usd
CY2022 aiad Third Parties Revenues
ThirdPartiesRevenues
6744297 usd
CY2022 us-gaap Revenues Net Of Interest Expense
RevenuesNetOfInterestExpense
6744297 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
247530 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
535833 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
334364 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
1184982 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
246410 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
214598 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
72948 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
102659 usd
CY2023 us-gaap Depreciation
Depreciation
31813 usd
CY2022 us-gaap Depreciation
Depreciation
37553 usd
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2102 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
20973 usd
CY2023Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
20202 usd
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
20202 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Concentrations of Business and Credit Risk</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company operates in a single industry segment.  The Company markets its services to companies and individuals in many industries and geographic locations.  The Company’s operations are subject to rapid technological advancement and intense competition. Accounts receivable represent financial instruments with potential credit risk.  The Company typically offers its customers credit terms.  The Company makes periodic evaluations of the credit worthiness of its enterprise customers and other than obtaining deposits pursuant to its policies, it generally does not require collateral.  In the event of nonpayment, the Company has the ability to terminate services. As of December 31, 2023, the Company held cash and cash equivalents in the amount of $110,899 which was held in the operating bank accounts.  Of this amount, $0 is held in amounts exceeding the FDIC insured limit of $250,000 for each account.  For further discussion on Concentrations see footnote 10.  </p>
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
1831977 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1891371 usd
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
875566666 shares
CY2023 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
2913973046 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
117151512 shares
CY2022 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
1246467092 shares
CY2023 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
5942483 usd
CY2022 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
4694698 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
533386 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
791133 usd
CY2023 us-gaap Revenues
Revenues
8170957 usd
CY2022 us-gaap Revenues
Revenues
6744297 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-6265359 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-8489924 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5542258 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
20202 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20202 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
20202 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20202 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023 us-gaap Sale Of Stock Percentage Of Ownership Before Transaction
SaleOfStockPercentageOfOwnershipBeforeTransaction
0.50 pure
CY2023Q2 aiad Stock Issued During Period Shares Stock Options Exercise
StockIssuedDuringPeriodSharesStockOptionsExercise
9222228 shares
CY2022Q3 aiad Lowest Traded Price Percentage
LowestTradedPricePercentage
0.90 pure
CY2022 aiad Purchased Shares Of Common Stock
PurchasedSharesOfCommonStock
101411148 shares
CY2022 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
1020251 usd
CY2023Q2 us-gaap Share Price
SharePrice
0.0173
CY2023Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
3374 usd
CY2023Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
0.0081
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14814814 shares
CY2023Q3 aiad Cash Compensation
CashCompensation
10000 usd
CY2022 aiad Cash Compensation
CashCompensation
0 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0449 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0129 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.06 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.29 pure
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y6M
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y6M
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
162703869 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
162703869 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
162703869 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.048
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
162703869 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.048
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
162703869 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.048
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
162703869 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.048
CY2023 aiad Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableInPeriod
162703869 shares
CY2023 aiad Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Exercise Price Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePriceExercisable
0.048
CY2022 aiad Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableInPeriod
162703869 shares
CY2022 aiad Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Exercise Price Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePriceExercisable
0.048
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
162703869 shares
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10 pure
CY2022Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
2000 sqft
CY2022Q3 us-gaap Property Management Fee Revenue
PropertyManagementFeeRevenue
3333 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
3931 usd
CY2022 aiad Right Of Use Assets
RightOfUseAssets
70608 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
186706 usd
CY2022 aiad Addition Stock Option Exercised
AdditionStockOptionExercised
3000000 shares
CY2022 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
2278481 shares
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
2278 usd
CY2022 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
3190 usd
CY2022Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
2940 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.21 pure
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
6240380 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
5389394 usd
CY2023 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-6240380 usd
CY2022 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-5389397 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
29716097 usd
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 usd
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 usd
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
usd
CY2022 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
usd
CY2022 aiad Stock Issued During Period Value Stock Option Exercised Cashless Basis
StockIssuedDuringPeriodValueStockOptionExercisedCashlessBasis
usd
CY2022 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
usd
CY2023 aiad Stock Issued During Period Value Stock Option Exercised Cashless Basis
StockIssuedDuringPeriodValueStockOptionExercisedCashlessBasis
usd
CY2023 us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
usd
CY2023 us-gaap Other Noncash Expense
OtherNoncashExpense
usd
CY2023 aiad Increase Decrease Costs In Excess Of Billings
IncreaseDecreaseCostsInExcessOfBillings
usd
CY2023 aiad Increase Decrease In Customer Deposit
IncreaseDecreaseInCustomerDeposit
usd
CY2022 aiad Increase Decrease In Rightofuse Asset
IncreaseDecreaseInRightofuseAsset
usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
CY2023 aiad Proceeds From The Sale Of Discontinued Operations
ProceedsFromTheSaleOfDiscontinuedOperations
usd
CY2022 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
usd
CY2023 us-gaap Interest Paid
InterestPaid
usd
CY2022 us-gaap Interest Paid
InterestPaid
usd
CY2023 us-gaap Stock Issued1
StockIssued1
usd
CY2022 us-gaap Stock Issued1
StockIssued1
usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2023 aiad Change In Right Of Use Asset
ChangeInRightOfUseAsset
usd
CY2023 aiad Retired Stock Issuance
RetiredStockIssuance
usd
CY2023 aiad Revenue From Related Party
RevenueFromRelatedParty
usd
CY2022 aiad Revenue From Related Party
RevenueFromRelatedParty
usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023 aiad Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised
shares
CY2023 aiad Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercised Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisedFairValue
CY2022 aiad Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised
shares
CY2022 aiad Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercised Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisedFairValue
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2023 aiad Weighted Average Fair Value Of Warrants Other Than Option Granted During The Period
WeightedAverageFairValueOfWarrantsOtherThanOptionGrantedDuringThePeriod
CY2022 aiad Weighted Average Fair Value Of Warrants Other Than Option Granted During The Period
WeightedAverageFairValueOfWarrantsOtherThanOptionGrantedDuringThePeriod
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000743758
CY2023 dei No Trading Symbol Flag
NoTradingSymbolFlag
true

Files In Submission

Name View Source Status
0001213900-24-077916-index-headers.html Edgar Link pending
0001213900-24-077916-index.html Edgar Link pending
0001213900-24-077916.txt Edgar Link pending
0001213900-24-077916-xbrl.zip Edgar Link pending
aiad-20231231.xsd Edgar Link pending
ea0212289-10k_aiadvert.htm Edgar Link pending
ea021228901ex21-1_aiadvert.htm Edgar Link pending
ea021228901ex31-1_aiadvert.htm Edgar Link pending
ea021228901ex31-2_aiadvert.htm Edgar Link pending
ea021228901ex32-1_aiadvert.htm Edgar Link pending
ea021228901ex32-2_aiadvert.htm Edgar Link pending
aiad-20231231_cal.xml Edgar Link unprocessable
aiad-20231231_def.xml Edgar Link unprocessable
aiad-20231231_lab.xml Edgar Link unprocessable
aiad-20231231_pre.xml Edgar Link unprocessable
ea0212289-10k_aiadvert_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending